Par Drugs and Chemicals — 360° view

Par Drugs and Chemicals, a company in the Pharmaceuticals industry, reported revenue of ₹27 crore and net profit of ₹2.63 crore for the September 2026 quarter.

Par Drugs and Chemicals (NSE: PAR-BE) closed at ₹112.06 on 20 Nov 2026. Its market capitalisation is ₹138 crore and it trades at 10.6 times earnings.

Share price
₹112.06 (20 Nov 2026)
Market cap
₹138 Cr (20 Nov 2026)
P/E
10.61 (20 Nov 2026)
Revenue
₹27 Cr (September 2026 quarter)
Net profit
₹3 Cr (September 2026 quarter)
ROCE
14.6% (FY26)
ROE
9.95% (FY26)
Book value
₹97.0 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹139.94 / ₹101.70 (20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: PAR-BE

Incorporated in 1982, Par Drugs & Chemicals Ltd manufactures APIs and Fine Chemicals

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.